Sodium‐glucose co‐transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials

Many patients with type 1 diabetes (T1D) struggle to achieve glycaemic control and experience significant fluctuations in glucose concentrations, despite insulin treatment. Sodium‐glucose co‐transporter (SGLT)‐2 inhibitors and dual SGLT‐1/2 inhibitors increase glucose elimination via the kidneys and...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Obes Metab
主要な著者: Boeder, Schafer, Edelman, Steven V.
フォーマット: Artigo
言語:Inglês
出版事項: Blackwell Publishing Ltd 2019
主題:
An Overview of Therapeutic Developments Which Target The Sodium‐Glucose Co‐Transporter Proteins. Publication of this supplement has been made possible by unrestricted educational grants from Sanofi US and Boehringer Ingelheim (South Korea)
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899736/
https://ncbi.nlm.nih.gov/pubmed/31081593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13749
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料